Abstract: A method for conditioning and maintaining power transmitted to a customer load from a primary or secondary power supply is disclosed. The method includes receiving a first input from the power supply, converting the first input using a converter, and continuously adjusting at least one converter power parameter to satisfy at least one inverter power parameter. The method determines whether the first output transmitted from the converter to an inverter satisfies the at least one inverter power parameter. If the output satisfies the inverter power parameter, then power is supplied to the customer load without charging or discharging a high discharge battery stack. The method also includes monitoring primary power supply parameters and switching to the secondary power supply if the primary power supply parameter fails to satisfy the respective primary power supply parameter threshold.

Abstract: A system for providing a rapid threshold amount of power to a customer load during transfer between a primary power supply and a secondary power supply is disclosed. The system is electrically connected between a customer metering system and the customer load. The system includes a secondary power supply not in electrical connectivity with the primary power supply. The secondary power supply includes a secondary power supply source for generating electrical power, a switching module, and an energy storage system in electrical communication with the secondary power supply source and the switching module. The energy storage system includes a high discharge battery and is configured to rapidly discharge power to the customer load when the switching module switches between the primary power supply and the secondary power supply. The switching module includes at least one set of contacts in communication with at least one inverter of the secondary power supply.

Abstract: A system for providing a rapid threshold amount of power to a customer load during transfer between a primary power supply and a secondary power supply is disclosed. The system is electrically connected between a customer metering system and the customer load. The system includes a secondary power supply not in electrical connectivity with the primary power supply. The secondary power supply includes a secondary power supply source for generating electrical power, a switching module, and an energy storage system in electrical communication with the secondary power supply source and the switching module. The energy storage system includes a high discharge battery and is configured to rapidly discharge power to the customer load when the switching module switches between the primary power supply and the secondary power supply. The switching module includes at least one set of contacts in communication with at least one inverter of the secondary power supply.

Abstract: A system for providing a rapid threshold amount of power to a customer load during transfer between a primary power supply and a secondary power supply is disclosed. The system is electrically connected between a customer metering system and the customer load. The system includes a secondary power supply not in electrical connectivity with the primary power supply. The secondary power supply includes a secondary power supply source for generating electrical power, a switching module, and an energy storage system in electrical communication with the secondary power supply source and the switching module. The energy storage system includes a high discharge battery and is configured to rapidly discharge power to the customer load when the switching module switches between the primary power supply and the secondary power supply. The switching module includes at least one set of contacts in communication with at least one inverter of the secondary power supply.

Abstract: The present invention relates to a recombinant polynucleotide encoding a polygene coding for at least three polypeptides wherein at least one of the genes constituting the polygene is of non-viral origin, at least two of the polypeptides encoded by the genes constituting the polygene are each capable of at least transiently interacting with at least one other polypeptide encoded by a gene of said polygene, and the genes constituting the polygene are each connected to one another by a sequence coding for at least one protease cleavage site. The present invention also relates to polyproteins encoded by the polygene. Further embodiments of the present invention are a vector containing the recombinant polypeptide, a host cell containing the recombinant polypeptide and/or the vector and a non-human transgenic animal transformed with the recombinant polypeptide and/or the vector. The present invention also relates to methods for the production of the polynucleotide and for the manufacture of multiprotein complexes.

Abstract: The present invention relates to a recombinant polynucleotide encoding a polygene coding for at least three polypeptides wherein at least one of the genes constituting the polygene is of non-viral origin, at least two of the polypeptides encoded by the genes constituting the polygene are each capable of at least transiently interacting with at least one other polypeptide encoded by a gene of said polygene, and the genes constituting the polygene are each connected to one mother by a sequence coding for at least one protease cleavage site. The present invention also relates to polyproteins encoded by the polygene. Further embodiments of the present invention are a vector containing the recombinant polypeptide, a host cell containing the recombinant polypeptide and/or the vector and a non-human transgenic animal transformed with the recombinant polypeptide and/or the vector. The present invention also relates to methods for the production of the polynucleotide and for the manufacture of multiprotein complexes.

Abstract: Polynucleotides for multigene applications comprising a novel functional arrangement, as well as vectors, host cells, and recombinant animals comprising the polynucleotides are described. Methods for generating multigene expression cassettes, methods for producing multiprotein complexes in vitro and in vivo, and methods for producing a vaccine are also disclosed. Further encompassed are methods for screening protein complex interactions or modifications of proteins, and methods for in vitro or in vivo screening of candidate compounds capable of protein complex interactions, modifications of proteins, inhibiting protein complex interactions or inhibiting modifications of proteins. Methods of use of the polynucleotides, vectors, host cells or recombinant animals for (i) preparing a medicament for gene therapy, for (ii) the recombinant production of multiprotein complexes, (iii) for producing a vaccine, or (iv) for screening compounds of interest.

Abstract: The present invention relates to a recombinant polynucleotide encoding a polygene coding for at least three polypeptides wherein at least one of the genes constituting the polygene is of non-viral origin, at least two of the polypeptides encoded by the genes constituting the polygene are each capable of at least transiently interacting with at least one other polypeptide encoded by a gene of said polygene, and the genes constituting the polygene are each connected to one mother by a sequence coding for at least one protease cleavage site. The present invention also relates to polyproteins encoded by the polygene. Further embodiments of the present invention are a vector containing the recombinant polypeptide, a host cell containing the recombinant polypeptide and/or the vector and a non-human transgenic animal transformed with the recombinant polypeptide and/or the vector. The present invention also relates to methods for the production of the polynucleotide and for the manufacture of multiprotein complexes.

Abstract: The present invention relates to polynucleotides for multigene applications comprising a novel functional arrangement, as well as vectors, host cells, and recombinant animals comprising said polynucleotides. In addition, the present invention is directed to methods for generating multigene expression cassettes, methods for producing multiprotein complexes in vitro and in vivo, and methods for producing a vaccine. Furthermore, the present invention encompasses methods for screening protein complex interactions or modifications of proteins, and methods for the in vitro or in vivo screening of candidate compounds capable of protein complex interactions or modifications of proteins or capable of inhibiting protein complex interactions or inhibiting modifications of proteins.